BCG Binah Capital Group, Inc. - Common Stock
$1.51
Price · Aug 19, 2026
Fundamentals as of May 15, 2026
BCG Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.50
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $3
BCG Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BCG
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BCG
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BCG
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BCG
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BCG
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 9
| Metric | Trend | Q1 2026 |
|---|---|---|
| Revenue | $49M | |
| Operating Expenses | $46M | |
| Pretax Income | $3M | |
| Income Tax | $755.0K | |
| Net Income | $2M | |
| EPS (Basic) | $0.09 | |
| EPS (Diluted) | $0.09 | |
| Shares (Basic) | 16,751,000 | |
| Shares (Diluted) | 16,942,000 |
Balance Sheet 12
| Metric | Trend | Q1 2026 |
|---|---|---|
| PP&E (Net) | $298.0K | |
| Goodwill | $40M | |
| Intangibles | $583.0K | |
| Total Assets | $71M | |
| Total Liabilities | $51M | |
| Common Stock | $0 | |
| Paid-in Capital | $24M | |
| Retained Earnings | $-21M | |
| AOCI | $-38.0K | |
| Stockholders' Equity | $20M | |
| Liabilities + Equity | $71M | |
| Shares Outstanding | 16,810,131 |
Cash Flow 9
| Metric | Trend | Q1 2026 |
|---|---|---|
| D&A | $143.0K | |
| Stock-based Comp | $384.0K | |
| Deferred Tax | $-8.0K | |
| Operating Cash Flow | $538.0K | |
| CapEx | $11.0K | |
| Investing Cash Flow | $-11.0K | |
| Financing Cash Flow | $-717.0K | |
| Net Change in Cash | $-190.0K | |
| Free Cash Flow | $527.0K |
Profitability 4
| Metric | Trend | Q1 2026 |
|---|---|---|
| Net Margin | 3.9% | |
| Pretax Margin | 5.5% | |
| ROA | 2.7% | |
| ROE | 10.2% |
Efficiency 1
| Metric | Trend | Q1 2026 |
|---|---|---|
| Asset Turnover | 0.7 |
Valuation (TTM) 9
| Metric | Trend | Q1 2026 |
|---|---|---|
| Revenue TTM | $185M | |
| Net Income TTM | $4M | |
| Market Cap | $34M | |
| P/E | 11.8 | |
| P/S | 0.2 | |
| P/B | 1.7 | |
| P / Cash Flow | 62.8 | |
| P / FCF | 64.1 | |
| Earnings Yield | 8.5% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
- ImmunityBio (IBRX): One of the Best Performing Growth Stocks So Far in 2026
- Four ways to create a lasting cost advantage from AI
- ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China
- BCG consultant behind 'AI brain fry' study says she's 'pessimistic' humans can overcome it anytime soon
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 14 filers · $838K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (+6 vs prior Q) | 1 (-3 vs prior Q) | 2 (0 vs prior Q) | 1 (-1 vs prior Q) | +181K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $348,071 | 120,858 | 41.53% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $190,895 | 123,958 | 22.78% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $57,020 | 37,026 | 6.80% | Shares |
| GRIMES & Co WEALTH MANAGEMENT, LLC | $51,562 | 33,482 | 6.15% | Shares |
| CITADEL ADVISORS LLC | $49,888 | 32,395 | 5.95% | Shares |
| STATE STREET CORP | $38,654 | 25,100 | 4.61% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $33,885 | 22,003 | 4.04% | Shares |
| Keystone Wealth Services, LLC | $32,648 | 21,200 | 3.90% | Shares |
| UBS Group AG | $16,752 | 10,878 | 2.00% | Shares |
| CITIGROUP INC | $10,318 | 6,700 | 1.23% | Shares |
| Tower Research Capital LLC (TRC) | $6,577 | 4,271 | 0.78% | Shares |
| BlackRock, Inc. | $1,104 | 717 | 0.13% | Shares |
| Farther Finance Advisors, LLC | $770 | 500 | 0.09% | Shares |
| Caitong International Asset Management Co., Ltd | $2 | 1 | 0.00% | Shares |
Company insiders 6 insiders · 2 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Craig Gould | Chief Executive Officer | May 19, 2026 P | 1,019,906 | 1 | 0 | $5,040 |
| David M. Shane | Chief Financial Officer | May 19, 2026 P | 3,000 | 1 | 0 | $4,980 |
| David F. Crane II | Director | June 30, 2025 A | — | 0 | 0 | $0 |
| Daniel Hynes | Director | June 30, 2025 A | — | 0 | 0 | $0 |
| Joel E Marks | Director | June 30, 2025 A | — | 0 | 0 | $0 |
| MHC Securities LLC | 10% owner | March 15, 2024 A | 9,011,653 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 18 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| EWUS · iShares Trust | 0.23% | 37,607 SH | Aug. 8, 2026 | Daily |
| ISCF · iShares Trust | 0.10% | 252,654 SH | Aug. 8, 2026 | Daily |
| IEUS · iShares Trust | 0.07% | 49,088 SH | Aug. 8, 2026 | Daily |
| SCZ · iShares Trust | 0.03% | 1,580,832 SH | Aug. 8, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 1,643,152 SH | Aug. 8, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 27,316 SH | Aug. 8, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 996,975 SH | Aug. 8, 2026 | Daily |
| IEFA · iShares Trust | 0.00% | 3,019,476 SH | Aug. 8, 2026 | Daily |
| IDEV · iShares Trust | 0.00% | 475,242 SH | Aug. 8, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 732,717 SH | Aug. 8, 2026 | Daily |
| IEUR · iShares Trust | 0.00% | 66,635 SH | Aug. 8, 2026 | Daily |
| IWC · iShares Trust | 0.00% | 12,577 SH | Aug. 8, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 28,756 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 95,202 SH | Aug. 8, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 6,311,071 SH | Aug. 8, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 365,823 SH | Aug. 8, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 4,145,622 SH | Aug. 8, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 89,615 SH | Aug. 8, 2026 | Daily |